Business
Junior biotech’s shares jump 10% on good news out of the US
Image source: Getty Images
Neurizon Therapeutics Ltd (ASX: NUZ) shares are up more than 10% in early trade after the company said there had been a key development in the US for its lead investigational drug, NUZ-001.
The company stated that the US Food and Drug Administration (FDA) had lifted…
Continue Reading
-
General23 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
General18 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Noosa News22 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Noosa News20 hours agoNoosa Open Studios 2025 Art Trail kicks off today